1. Home
  2. EFOI vs CTXR Comparison

EFOI vs CTXR Comparison

Compare EFOI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFOI

Energy Focus Inc.

HOLD

Current Price

$2.71

Market Cap

21.0M

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

N/A

Current Price

$0.60

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EFOI
CTXR
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
18.7M
IPO Year
2004
2010

Fundamental Metrics

Financial Performance
Metric
EFOI
CTXR
Price
$2.71
$0.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
7.8K
898.3K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
43.38
EPS
N/A
N/A
Revenue
$3,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.47
52 Week High
$9.84
$2.19

Technical Indicators

Market Signals
Indicator
EFOI
CTXR
Relative Strength Index (RSI) 39.80 48.01
Support Level $1.98 $0.51
Resistance Level $2.79 $0.61
Average True Range (ATR) 0.12 0.08
MACD -0.03 -0.01
Stochastic Oscillator 20.23 17.81

Price Performance

Historical Comparison
EFOI
CTXR

About EFOI Energy Focus Inc.

Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: